Health Literacy and Barriers to Engaging People in Clinical Trials - 2023
Dana-Farber Cancer Institute via YouTube
Overview
Learn about health literacy challenges and barriers to clinical trial participation for individuals with inherited mutations in this 44-minute conference presentation from the 2023 Dana-Farber Cancer Institute Center for BRCA and Related Genes Scientific Symposium. Explore key insights from Sue Friedman, DVM, founder of FORCE: Facing Our Risk of Cancer Empowered, as she discusses strategies for improving engagement throughout the clinical trial lifecycle and addresses the unique challenges faced by patients with inherited genetic mutations. Gain valuable perspectives on making clinical research more accessible and inclusive for this specific patient population while understanding the role of health literacy in research participation.
Syllabus
Health Literacy & Barriers to Engaging People in Clinical Trials | 2023 BRCA Scientific Symposium
Taught by
Dana-Farber Cancer Institute